MRO Magazine

PixarBio Cofounder Robert S. Langer Awarded The 2015 Queen Elizabeth Prize for Engineering (QEPrize) for His Medical Inventions Impacting Over Two Billion Lives


November 2, 2015
By Business Wire News

CAMBRIDGE, Mass.

PixarBio Corporation is proud to announce that our cofounder Robert S. Langer has been awarded the 2015 Queen Elizabeth Prize (QEPrize) presented by Queen Elizabeth on Tuesday, October 27, 2015 at the Throne Room in Buckingham Palace London.

The Queen Elizabeth Prize for Engineering is a global £1 million prize that celebrates a ground-breaking innovation in engineering. The prize rewards an individual or team of engineers whose work has had a major impact on humanity in the past with continued promise for the future.

While doing so, the prize also celebrates engineering as a discipline and career choice, shining light on the excitement and importance of engineering and inspiring young people to get involved in the subject. The fruits of engineering range from nano-scale devices that get medicines to where they are needed in the body to the world’s biggest – and greenest – buildings; from the pinpoint accuracy of robots that perform heart surgery to the proliferation of ever-faster multiplatform broadband applications; from hi-tech fabrics to make the smart clothes of the future to new, clean and green sources of energy to power the world.

The QEPrize celebrate stories of these engineering successes, raising the international public profile of engineering and inspiring new generations of engineers to take up the challenges of the future. It’s been awarded just once before in 2013 to internet pioneers Marc Andreessen, Sir Tim Berners-Lee, Vinton Cerf, Robert Kahn, and Louis Pouzin.

Robert S. Langer was awarded the QEPrize for his revolutionary advances and leadership in engineering at the interface with chemistry and medicine. Robert S. Langer was the first person to engineer polymers to control the delivery of large molecular weight drugs for the treatment of diseases such as cancer and mental illness. Over 2 billion lives have been improved worldwide by the technologies that Robert S. Langer’s lab has created.

“Whether it’s cofounding the fields of angiogenesis inhibitors for cancer, tissue engineering for organ repair and growth or drug delivery for so many others, Bob has shaped the medical care for billions of people.” said PixarBio CEO Frank Reynolds.

About PixarBio Corporation

Cofounded by Frank Reynolds, MIT’s Robert S. Langer, Katrin Holzhaus, and Jason Criscione, PixarBio is focused on researching and developing targeted delivery systems to treat pain, epilepsy, Parkinson’s disease, and spinal cord injury. For more information visit www.pixarbio.com.

PixarBio Corporation
Glenn Reiser, 617-386-6795
Investor Relations
greiser@pixarbio.com